Professional
Added to YB: 2025-11-20
Pitch date: 2025-09-30
PBH [neutral]
Prestige Consumer Healthcare Inc.
-1.37%
current return
Author Info
No bio for this author
Company Info
Prestige Consumer Healthcare Inc., together with its subsidiaries, develops, manufactures, markets, distributes, and sells over the counter (OTC) health and personal care products in North America, Australia, and internationally.
Market Cap
$2.8B
Pitch Price
$62.72
Price Target
N/A
Dividend
N/A
EV/EBITDA
9.08
P/E
14.59
EV/Sales
3.38
Sector
Pharmaceuticals
Category
turnaround
Heartland Value Plus Fund Portfolio Holding: Prestige Consumer Healthcare Inc.
PBH (holding update): Q detractor on missed earnings & lowered FY EPS due to Clear Eyes supply chain issues. Acquired eye care supplier for $100M to fix problem. Expect FY2027 earnings rebound as core biz strong & eye care restocks. Trading 13.8x 2027 EPS at $63, anticipating multiple expansion.
Read full article (1 min)